Protect your brain and body at the cellular level with NAC (N-Acetyl L-Cysteine).*
Liraglutide reduces A1C by an average of 1-1.5%
The meta-analysis evaluated the relative efficacy and safety of various GLP-1 RAs, including dulaglutide, exenatide, liraglutide, lixisenatide, and once-weekly semaglutide injections ( The model parameters were derived from data obtained from the PIONEER 8 trial and additional unreported data from UKPDS (Supplementary Table S1 displays the baseline characteristics of a simulated cohort comprising 1,000 subjects in each intervention group, with a mean age of 61.0 10.0 years and a mean HbA1c of 8.2% 0.7%
The FDA has approved semaglutide under two brand names: Ozempic for type 2 diabetes management and Wegovy for chronic weight management
We also serve the following states: Arizona, California, Connecticut, Michigan, Oregon, Pennsylvania, Virginia with more to come